Saol Therapeutics and GeneDx have partnered to identify patients with rare mitochondrial disease. There are currently no FDA-approved treatments for patients with PDCD so this is a huge step in the right direction:
Saol Therapeutics, GeneDx Partner to ID Patients With Rare Mitochondrial Disease
Connect With Confidence.
We guarantee to pour our resources into finding top-notch talent for you, bringing depth, determination and dedication to each and every recruiting project.